Document Detail


Midterm to long-term longitudinal outcome of autologous chondrocyte implantation in the knee joint: a multilevel analysis.
MedLine Citation:
PMID:  19861698     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Autologous chondrocyte implantation is a cell therapeutic approach for the treatment of chondral and osteochondral defects in the knee joint. The authors previously reported on the histologic and radiologic outcome of autologous chondrocyte implantation in the short- to midterm, which yields mixed results. PURPOSE: The objective is to report on the clinical outcome of autologous chondrocyte implantation for the knee in the midterm to long term. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Eighty patients who had undergone autologous chondrocyte implantation of the knee with mid- to long-term follow-up were analyzed. The mean patient age was 34.6 years (standard deviation, 9.1 years), with 63 men and 17 women. Seventy-one patients presented with a focal chondral defect, with a median defect area of 4.1 cm(2) and a maximum defect area of 20 cm(2). The modified Lysholm score was used as a self-reporting clinical outcome measure to determine the following: (1) What is the typical pattern over time of clinical outcome after autologous chondrocyte implantation; and (2) Which patient-related predictors for the clinical outcome pattern can be used to improve patient selection for autologous chondrocyte implantation? RESULTS: The average follow-up time was 5 years (range, 2.7-9.3). Improvement in clinical outcome was found in 65 patients (81%), while 15 patients (19%) showed a decline in outcome. The median preoperative Lysholm score of 54 increased to a median of 78 points. The most rapid improvement in Lysholm score was over the 15-month period after operation, after which the Lysholm score remained constant for up to 9 years. The authors were unable to identify any patient-specific factors (ie, age, gender, defect size, defect location, number of previous operations, preoperative Lysholm score) that could predict the change in clinical outcome in the first 15 months. CONCLUSION: Autologous chondrocyte implantation seems to provide a durable clinical outcome in those patients demonstrating success at 15 months after operation. Comparisons between other outcome measures of autologous chondrocyte implantation should be focused on the clinical status at 15 months after surgery. The patient-reported clinical outcome at 15 months is a major predictor of the mid- to long-term success of autologous chondrocyte implantation.
Authors:
Abhijit M Bhosale; Jan Herman Kuiper; W Eustace B Johnson; Paul E Harrison; James B Richardson
Related Documents :
1447238 - Soft-tissue balance and alignment in medial unicompartmental knee arthroplasty.
24036978 - Influence of the interposition of ceramic spacers on the degree of conversion and the h...
17004268 - Effects of knee simulator loading and alignment variability on predicted implant mechan...
23864828 - Effects of using pozzolan and portland cement in the treatment of dispersive clay.
9231258 - A comparison of dissected follicle numbers and follicle counts on the ovarian surface f...
21135178 - Quaternized chitosan inhibits icaa transcription and biofilm formation by staphylococcu...
Publication Detail:
Type:  Journal Article     Date:  2009-10-27
Journal Detail:
Title:  The American journal of sports medicine     Volume:  37 Suppl 1     ISSN:  1552-3365     ISO Abbreviation:  Am J Sports Med     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7609541     Medline TA:  Am J Sports Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  131S-8S     Citation Subset:  IM    
Affiliation:
Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Oswestry, UK. abhosale05@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for oste...
Next Document:  Recommendations and Treatment Outcomes for Patellofemoral Articular Cartilage Defects With Autologou...